Pregabalin and Gabapentin Prospective Clinical Trial for the Treatment of Sciatica: A Randomised, Double-Blind, Cross-over Study.

Trial Profile

Pregabalin and Gabapentin Prospective Clinical Trial for the Treatment of Sciatica: A Randomised, Double-Blind, Cross-over Study.

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Pregabalin (Primary) ; Gabapentin
  • Indications Sciatica
  • Focus Therapeutic Use
  • Acronyms PAGPROS
  • Most Recent Events

    • 01 Oct 2015 Planned initiation date changed from 1 Jul 2015 to 1 Jul 2016 as per Australian New Zealand Clinical Trials Registry.
    • 01 Oct 2015 Planned number of patients changed from 100 to 36 as per Australian New Zealand Clinical Trials Registry.
    • 21 May 2015 Planned number of patients changed from 200 to 100 as per Australian New Zealand Clinical Trials Registry.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top